WO2008025926A3 - Substitut salivaire - Google Patents

Substitut salivaire Download PDF

Info

Publication number
WO2008025926A3
WO2008025926A3 PCT/FR2007/051850 FR2007051850W WO2008025926A3 WO 2008025926 A3 WO2008025926 A3 WO 2008025926A3 FR 2007051850 W FR2007051850 W FR 2007051850W WO 2008025926 A3 WO2008025926 A3 WO 2008025926A3
Authority
WO
WIPO (PCT)
Prior art keywords
salivary substitute
salivary
substitute
rheological
packaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2007/051850
Other languages
English (en)
Other versions
WO2008025926A2 (fr
Inventor
Jean Deymes
Philippe Perovitch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unither Developpement
Original Assignee
Unither Developpement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unither Developpement filed Critical Unither Developpement
Priority to RU2009111875/15A priority Critical patent/RU2472515C2/ru
Priority to CA2661694A priority patent/CA2661694C/fr
Priority to PL07823749T priority patent/PL2056846T3/pl
Priority to AU2007291133A priority patent/AU2007291133B2/en
Priority to EP07823749.2A priority patent/EP2056846B1/fr
Priority to ES07823749T priority patent/ES2424657T3/es
Priority to BRPI0714755A priority patent/BRPI0714755B8/pt
Priority to US12/439,362 priority patent/US8216616B2/en
Priority to JP2009526154A priority patent/JP2010501640A/ja
Publication of WO2008025926A2 publication Critical patent/WO2008025926A2/fr
Publication of WO2008025926A3 publication Critical patent/WO2008025926A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'objet de l'invention est un substitut salivaire réalisé à partir de blanc d'oeuf de façon à présenter des propriétés chimiques, rhéologiques et physiologiques analogues à celles de la salive humaine naturelle. L'invention concerne également ses utilisations et son conditionnement.
PCT/FR2007/051850 2006-09-01 2007-08-28 Substitut salivaire Ceased WO2008025926A2 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
RU2009111875/15A RU2472515C2 (ru) 2006-09-01 2007-08-28 Заменитель слюны
CA2661694A CA2661694C (fr) 2006-09-01 2007-08-28 Substitut salivaire
PL07823749T PL2056846T3 (pl) 2006-09-01 2007-08-28 Substytut śliny
AU2007291133A AU2007291133B2 (en) 2006-09-01 2007-08-28 Salivary substitute
EP07823749.2A EP2056846B1 (fr) 2006-09-01 2007-08-28 Substitut salivaire
ES07823749T ES2424657T3 (es) 2006-09-01 2007-08-28 Sustituto salivar
BRPI0714755A BRPI0714755B8 (pt) 2006-09-01 2007-08-28 substituto salivar e receptáculo para substituto salivar
US12/439,362 US8216616B2 (en) 2006-09-01 2007-08-28 Salivary substitute
JP2009526154A JP2010501640A (ja) 2006-09-01 2007-08-28 唾液代替剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0653549A FR2905268B1 (fr) 2006-09-01 2006-09-01 Substitut salivaire
FR0653549 2006-09-01

Publications (2)

Publication Number Publication Date
WO2008025926A2 WO2008025926A2 (fr) 2008-03-06
WO2008025926A3 true WO2008025926A3 (fr) 2008-04-17

Family

ID=37873194

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2007/051850 Ceased WO2008025926A2 (fr) 2006-09-01 2007-08-28 Substitut salivaire

Country Status (12)

Country Link
US (1) US8216616B2 (fr)
EP (1) EP2056846B1 (fr)
JP (1) JP2010501640A (fr)
CN (1) CN101553239A (fr)
AU (1) AU2007291133B2 (fr)
BR (1) BRPI0714755B8 (fr)
CA (1) CA2661694C (fr)
ES (1) ES2424657T3 (fr)
FR (1) FR2905268B1 (fr)
PL (1) PL2056846T3 (fr)
RU (1) RU2472515C2 (fr)
WO (1) WO2008025926A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2116139A1 (fr) * 2008-05-08 2009-11-11 Nestec S.A. Acide sialique pour le support de la santé mentale des personnes âgées
EP2116140A1 (fr) * 2008-05-08 2009-11-11 Nestec S.A. Acide sialique pour le support du système immunitaire chez les personnes âgées
CN103025321A (zh) 2010-03-23 2013-04-03 生物联合制药公司 快速溶解的药物释放系统
US20110237563A1 (en) * 2010-03-23 2011-09-29 Dominique Costantini Fast dissolving drug delivery systems
EP2377526A1 (fr) 2010-03-23 2011-10-19 BioAlliance Pharma Systèmes d'administration de médicaments à dissolution rapide
KR101304766B1 (ko) * 2011-01-05 2013-09-05 서울대학교산학협력단 히알루론산을 포함하는 인공타액
KR101498510B1 (ko) * 2012-06-26 2015-03-04 서울대학교산학협력단 히알루론산을 포함하는 인공 타액 조성물
CN111012901B (zh) * 2020-01-10 2021-11-16 华中农业大学 一种含有卵粘蛋白和溶菌酶的人工唾液及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999004804A1 (fr) * 1997-07-25 1999-02-04 Michael Anthony Folan Secretions immunes maternelles et leur utilisation dans le traitement et/ou la prophylaxie d'etats du corps humain
US20050226822A1 (en) * 2002-04-25 2005-10-13 Gaba International Ag Oral care products containing ovomucin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2590550B1 (fr) * 1985-11-26 1988-01-15 Atochem Recipients composites metalloplastiques assembles par soudure et leur procede de fabrication
US5541165A (en) * 1994-09-27 1996-07-30 Turgeon; Jean A. Saliva substitute
US5860806A (en) * 1996-11-29 1999-01-19 The Kerr Corporation Single dose dental adhesive delivery system and method and adhesive therefor
RU2139069C1 (ru) * 1998-10-07 1999-10-10 Лях Светлана Павловна Средство для лечения патологических состояний "астромеланин"/"астронэлла")
PL206441B1 (pl) * 1999-10-12 2010-08-31 Blis Technologies Ltd Przeciwbakteryjne białko, zawierająca je kompozycja przeciwbakteryjna, preparat terapeutyczny, polinukleotydy, wyizolowany organizm, szczepy, zastosowanie białka
RU2362552C1 (ru) * 2008-05-26 2009-07-27 Государственное образовательное учреждение высшего профессионального образования "Уральская государственная медицинская академия" Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО УГМА Росздрава) Препарат для заместительной терапии при сухости в полости рта

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999004804A1 (fr) * 1997-07-25 1999-02-04 Michael Anthony Folan Secretions immunes maternelles et leur utilisation dans le traitement et/ou la prophylaxie d'etats du corps humain
US20050226822A1 (en) * 2002-04-25 2005-10-13 Gaba International Ag Oral care products containing ovomucin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WOLINSKY L E ET AL: "The inhibiting effect of aqueous Azadirachta indica (neem) extract upon bacterial properties influencing in vitro plaque formation", JOURNAL OF DENTAL RESEARCH, vol. 75, no. 2, 1996, pages 816 - 822, XP002426645, ISSN: 0022-0345 *

Also Published As

Publication number Publication date
ES2424657T3 (es) 2013-10-07
RU2009111875A (ru) 2010-10-10
JP2010501640A (ja) 2010-01-21
RU2472515C2 (ru) 2013-01-20
PL2056846T3 (pl) 2013-10-31
FR2905268B1 (fr) 2009-01-23
US8216616B2 (en) 2012-07-10
EP2056846A2 (fr) 2009-05-13
BRPI0714755A2 (pt) 2013-05-14
BRPI0714755B1 (pt) 2019-10-01
CN101553239A (zh) 2009-10-07
AU2007291133A1 (en) 2008-03-06
CA2661694C (fr) 2014-05-13
US20090317484A1 (en) 2009-12-24
CA2661694A1 (fr) 2008-03-06
WO2008025926A2 (fr) 2008-03-06
BRPI0714755B8 (pt) 2021-07-27
FR2905268A1 (fr) 2008-03-07
EP2056846B1 (fr) 2013-07-03
AU2007291133B2 (en) 2013-03-21

Similar Documents

Publication Publication Date Title
WO2008025926A3 (fr) Substitut salivaire
WO2008130989A3 (fr) Implants prothétiques
PH12013502192A1 (en) Antibodies against human angiopoietin 2
WO2010029278A3 (fr) Isolement et identification de glycosaminoglycanes
WO2006052451A3 (fr) Compositions de collagene implantables
DK1841332T3 (da) Fortykningskomposition til dysfagi patienter
EP1919302B8 (fr) Aliment contenant du silicium
MX2008002278A (es) Acido graso de aceite de bogol bajo en azufre.
WO2008066784A3 (fr) Expression de foxp3 par des cellules cancéreuses
WO2008017079A3 (fr) Teintures et précurseurs et leurs conjugués
WO2008046865A3 (fr) Système d'alimentation à long terme pour personnes agées
WO2009007532A3 (fr) Utilisation d'une hemoglobine pour la preparation de pansements, et pansements ainsi prepares
EP2041205A4 (fr) Compositions de silicone rtv de faible module résistantes à l'humidité, et leurs procédés de préparation
WO2009100275A3 (fr) Compositions et dispositifs
WO2007144779A3 (fr) Compositions comprenant des porphyra et procédés d'utilisation de celles-ci
TW200716525A (en) Process for preparation of sulfamide derivatives
WO2009149030A3 (fr) Compositions de soin buccal et procédés
WO2005009421A8 (fr) Utilisation de composes d'1-amino-alkylcyclohexane dans le traitement de l'hypersensibilite a la douleur
EP1609375A4 (fr) Aliment contenant de la glycine
EP1863495A4 (fr) Sel de calcium de myo-inositol 1,6:2,3:4,5 tripyrophosphate utile comme effecteur allosterique de l'hemoglobine
WO2007064304A8 (fr) Composition biocompatible et utilisations de celle-ci
WO2007101602A3 (fr) Domaines kunitz chimeriques et utilisation associee
WO2009103754A3 (fr) Nouvelle utilisation de 3,3'-diindolylméthane
WO2005110413A3 (fr) Medicaments contenant des n-sulfamoyl-n'-arylpiperazines utilises pour la prophylaxie ou le traitement de l'obesite et des pathologies apparentees
WO2007061888A3 (fr) Chewing-gum dégradable

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780031964.0

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07823749

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2661694

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2009526154

Country of ref document: JP

Ref document number: 2007823749

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12439362

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007291133

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2009111875

Country of ref document: RU

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2007291133

Country of ref document: AU

Date of ref document: 20070828

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: PI0714755

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20090302